High level expression of the two outer capsid proteins of bluetongue virus serotype 10: their relationship with the neutralization of virus infection.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Virus Research

• Publication date

  1990-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0168-1702(90)90027-9PMID 2160763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complete sequence of neutralization protein VP2 of the recent US isolate bluetongue virus serotype 2: its relationship with VP2 species of other US serotypes.

  1988cited by this paper
• Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep.

  1987cited by this paper
• Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins.

  1987cited by this paper
• Production and characterization of the neutralization antigen VP2 of bluetongue virus serotype 10 using a baculovirus expression vector.

  1987cited by this paper
• Nucleotide sequence of cDNA clones encoding the outer capsid protein, VP5, of bluetongue virus serotype 10.

  1986cited by this paper
• Supercoil sequencing: a fast method for sequencing plasmid DNA

  1985cited by this paper
• Supercoil Sequencing: A Fast and Simple Method for Sequencing Plasmid DNA

  1985cited by this paper
• Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode.

  1984cited by this paper
• Molecular basis of bluetongue virus neutralization

  1983cited by this paper
• Identification of the serotype-specific and group-specific antigens of bluetongue virus.

  1981cited by this paper
• Detection of specific sequences among DNA fragments separated by gel electrophoresis.

  1975cited by this paper
• Structure of the Bluetongue Virus Capsid

  1972cited by this paper
• Properties of minor nucleoprotein components found in TYMV preparations.

  1972cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Detection, genetic characterization and reassortment analysis of Tribeč virus

  2026cites this paper
• Impact of VP2 structure on antigenicity: comparison of BTV1 and the highly virulent BTV8 serotype

  2024cites this paper
• Desarrollo de vacunas recombinantes marcadoras multiserotipo frente al virus de la lengua azul

  2017cites this paper
• Development of plant-produced protein body vaccine candidates for bluetongue virus

  2017cites this paper
• Identifying B-cell epitopes of African horse sickness virus serotype 4 recognised by antisera of immunised horses

  2016cites this paper
• Understanding the early events in Bluetongue virus cell entry

  2016cites this paper
• Trafficking of Bluetongue Virus Visualized by Recovery of Tetracysteine-Tagged Virion Particles

  2014cites this paper
• Development of plant-produced Bluetongue virus vaccines

  2014cites this paper
• Functional characterization of the African horse sickness virus VP5 protein, and studies regarding virus-induced apoptosis in cultured mammalian cells

  2012cites this paper
• Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.

  2012cites this paper
• Mapping the function of the NS3 protein of African horsesickness virus using RNAi and yeast two-hybrid analyses

  2011cites this paper
• Oncolytic Bluetongue Viruses: Promise, Progress, and Perspectives

  2011influential citation
• Generation of Replication-Defective Virus-Based Vaccines That Confer Full Protection in Sheep against Virulent Bluetongue Virus Challenge

  2011cites this paper
• Viral Expression Vectors

  2011cites this paper
• Characterization of Protection Afforded by a Bivalent Virus-Like Particle Vaccine against Bluetongue Virus Serotypes 1 and 4 in Sheep

  2011cites this paper
• Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus.

  2010cites this paper
• Tubules composed of non-structural protein NS1 of african horsesickness virus as system for the immune display of foreign peptides

  2010cites this paper
• Silencing of African horse sickness virus NS2 gene expression using vector-derived short hairpin RNAs

  2010cites this paper
• Suppression of African horse sickness virus NS1 protein expression in mammalian cells by short hairpin RNAs

  2009cites this paper
• Silencing African horsesickness virus VP7 protein expression in vitro by RNA interference

  2008cites this paper
• Bluetongue Virus Outer Capsid Protein VP5 Interacts with Membrane Lipid Rafts via a SNARE Domain

  2008cites this paper
• Interaction between Bluetongue virus outer capsid protein VP2 and vimentin is necessary for virus egress

  2007cites this paper
• The major core proteins : VP 3 and VP 7

  2007cites this paper
• Assembly and Intracellular Localization of the Bluetongue Virus Core Protein VP3

  2005cites this paper
• A capsid protein of nonenveloped Bluetongue virus exhibits membrane fusion activity

  2004cites this paper
• Mapping the assembly pathway of Bluetongue virus scaffolding protein VP3.

  2004cites this paper
• Interactions between the Inner and Outer Capsids of Bluetongue Virus

  2004cites this paper
• Expression and Functional Characterization of Bluetongue Virus VP5 Protein: Role in Cellular Permeabilization

  2001cites this paper
• Definition of neutralizing sites on African horse sickness virus serotype 4 VP2 at the level of peptides.

  2001cites this paper
• Cloning and expression of the M5 RNA segment encoding outer capsid VP5 of epizootic hemorrhagic disease virus Japan serotype 2, Ibaraki virus.

  2000cites this paper
• Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus.

  1999cites this paper
• Expression and Functional Characterization of Bluetongue Virus VP2 Protein: Role in Cell Entry

  1999cites this paper
• Comparative sequence analysis and expression of the M6 gene, encoding the outer capsid protein VP5, of African horsesickness virus serotype nine.

  1997cites this paper
• Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.

  1997cites this paper
• Synthesis of bluetongue virus chimeric VP3 molecules and their interactions with VP7 protein to assemble into virus core-like particles.

  1995cites this paper
• Synthesis of recombinant baculoviruses expressing the outer capsid protein VP2 of five BTV serotypes and the induction of neutralizing antibodies to homologous and heterologous BTV serotypes.

  1994cites this paper
• Expression of the outer capsid proteins VP2 and VP5 of bluetongue virus in Saccharomyces cerevisiae.

  1994cites this paper
• Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization.

  1994cites this paper
• Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.

  1994cites this paper
• Association of bluetongue virus gene segment 5 with neuroinvasiveness

  1994influential citation
• African horse sickness virus structure.

  1994cites this paper
• Genetically engineered multi‐component virus‐like particles as veterinary vaccines

  1993cites this paper
• Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells.

  1993cites this paper
• Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2.

  1993cites this paper
• Genetically Engineered Bluetongue Virus-Like Particles and Their Potential for Use as Vaccine in Sheep

  1993cites this paper
• Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A.

  1993cites this paper
• Differential serologic responses to reassortant bluetongue viruses recovered from a bull

  1993cites this paper
• Interactions between bluetongue virus core and capsid proteins translated in vitro.

  1992cites this paper
• Bluetongue virus proteins.

  1992cites this paper
• The baculovirus-infected insect cell as a eukaryotic gene expression system.

  1992cites this paper
• High level expression of the major core protein VP7 and the non-structural protein NS3 of bluetongue virus in yeast: use of expressed VP7 as a diagnostic, group-reactive antigen in a blocking ELISA.

  1991cites this paper
• Expression of the outer capsid protein VP5 of two bluetongue viruses, and synthesis of chimeric double-shelled virus-like particles using combinations of recombinant baculoviruses.

  1991cites this paper
• Complete nucleotide and deduced amino acid sequence of genome segment 5 encoding the outer capsid protein, VP5, of a U.S. isolate of bluetongue virus serotype 11.

  1991cites this paper
• Synthesis and characterization of chimeric particles between epizootic hemorrhagic disease virus and bluetongue virus: functional domains are conserved on the VP3 protein

  1991cites this paper
• Structure of the bluetongue virus genome and its encoded proteins.

  1990cites this paper
• Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins

  1990cites this paper
• Gene expression using insect cells and viruses.

  1990cites this paper